Items where authors include "Beer, S."

Article

Abani, O., Abbas, A., Abbas, F. et al. (8041 more authors) (2025) Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Infectious Diseases. ISSN 1473-3099

Chen, J.-L., Wang, B. orcid.org/0000-0002-3746-0188, Lu, Y. orcid.org/0000-0003-4701-5560 et al. (127 more authors) (2025) T cell memory response to MPXV infection exhibits greater effector function and migratory potential compared to MVA-BN vaccination. Nature Communications, 16. 4362. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (8021 more authors) (2025) Higher dose corticosteroids in hospitalised COVID-19 patients requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. eClinicalMedicine, 81. 103080. ISSN 2589-5370

Uzokwe, C.A. orcid.org/0000-0002-3782-1385, Nkwoala, C.C., Ebenso, B.E. et al. (7 more authors) (2024) Development and Pilot Study of myfood24 West Africa—An Online Tool for Dietary Assessment in Nigeria. Nutrients, 16 (20). 3497. ISSN 2072-6643

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Faust, S.N., Haynes, R., Jones, C.E. et al. (7370 more authors) (2024) Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Child & Adolescent Health, 8 (3). pp. 190-200. ISSN 2352-4642

Sandercock, P., Darbyshire, J., DeMets, D. et al. (2050 more authors) (2024) Dimethyl fumarate in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Nature Communications, 15. 924. ISSN 2041-1723

Abani, O., Abbas, A., Abbas, F. et al. (7989 more authors) (2023) Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet Diabetes & Endocrinology, 11 (12). pp. 905-914. ISSN 2213-8587

Abani, O., Abbas, A., Abbas, F. et al. (8104 more authors) (2023) Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial. The Lancet, 401 (10387). pp. 1499-1507. ISSN 0140-6736

Adams, E.R., Ainsworth, M., Anand, R. et al. (69 more authors) (2020) Antibody testing for COVID-19: a report from the National COVID Scientific Advisory Panel [version 1; peer review: 2 approved]. Wellcome Open Research, 5. 139. ISSN 2398-502X

Conference or Workshop Item

Cade, J.E. orcid.org/0000-0003-3421-0121, Rycroft, C., Beer, S. et al. (1 more author) (2024) Collecting regional data for public health focusing on diet and sustainability measures using myfood24. In: Nutrition Society Congress 2024, 02-05 Jul 2024, Belfast, NI.

Proceedings Paper

Uzokwe, C.A., Ebenso, B.E. orcid.org/0000-0003-4147-0968, Williams, G. et al. (2 more authors) (2024) Assessing diet more accurately in Nigeria - development of myfood24 West Africa. In: Proceedings of the Nutrition Society. Summer Conference 2023, Nutrition at key stages of the lifecycle, 03-06 Jul 2023, Liverpool, UK. Cambridge University Press , E279.

Threapleton, D., Cade, J., Beer, S. et al. (3 more authors) (2023) Can a new diet tracking app, myfood24 healthcare, support tier 3 weight management and gastroenterology surgery patients? A feasibility randomised controlled trial. In: Annals of Nutrition and Metabolism. IUNS 22nd International Congress of Nutrition, 06-11 Dec 2022, Tokyo, Japan. Karger , pp. 705-706.